Our paper on Tau SH3 interactions as a therapeutic target for Alzheimer's disease is published in Neurobiology of Disease.
Paper: “A peptide inhibitor of Tau-SH3 interactions ameliorates amyloid-β toxicity”
Our paper on Tau SH3 interactions as a therapeutic target for Alzheimer's disease is published in Neurobiology of Disease.
Paper: “A peptide inhibitor of Tau-SH3 interactions ameliorates amyloid-β toxicity”